LRP11 has been shown to drive tumor cell proliferation and metastasis in triple-negative breast cancer via the miR-149-3p/NRP2 axis [53], and its upregulation here correlates with the observed migratory phenotype. Here, NRP2 is linked to triple-negative breast carcinoma.